Inventor · Shanghai, CN

Hao Wu

41Patents
6h-index
150Co-inventors
68Inventor score

Filing activity: Feb 20, 2010 → May 25, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8871759B2 Inhibitors of hepatitis C virus replication Chemistry; Metallurgy 49 Active
US9938292B2 Quinoline derivatives as SMO inhibitors Chemistry; Metallurgy 18 Active
US9962388B2 Pyrrolopyrimidine compounds used as TLR7 agonist Chemistry; Metallurgy 9 Active
US9090661B2 Inhibitors of hepatitis C virus replication Chemistry; Metallurgy 6 Active
US9718828B2 BTK Inhibitors Chemistry; Metallurgy 6 Active
US9573939B2 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Emerging Cross-Sectional Technologies 6 Active
US10745389B2 HDAC6 selective inhibitors, preparation method therefor, and application thereof Chemistry; Metallurgy 3 Active
US11434476B2 Methods of editing DNA methylation Chemistry; Metallurgy 3 Active
US9481682B2 Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors Emerging Cross-Sectional Technologies 1 Active
US10555949B2 Pyrrolopyrimidine compounds used as TLR7 agonist Chemistry; Metallurgy 1 Active
US9549917B2 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases Emerging Cross-Sectional Technologies 1 Active
US10597413B2 Silicone-compatible compounds Chemistry; Metallurgy 1 Active
US10087188B2 Benzamide imidazopyrazine Btk inhibitors Chemistry; Metallurgy 0 Active
US9505739B2 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease Chemistry; Metallurgy 0 Active
US8450454B2 Compositions for inhibiting ABAD/ABeta protein interaction Human Necessities 0 Active
US11466013B2 ERK inhibitor and use thereof Chemistry; Metallurgy 0 Active
US8865701B2 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease Chemistry; Metallurgy 0 Active
US11053243B2 Inhibitors of hepatitis C virus replication Chemistry; Metallurgy 0 Active
US11926633B2 Synthesis methods for upadacitinib and intermediate thereof Emerging Cross-Sectional Technologies 0 Active
US12060588B2 Methods of editing DNA methylation Chemistry; Metallurgy 0 Active
US9446130B2 BTK inhibitors Chemistry; Metallurgy 0 Active
US11045458B2 Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing them Chemistry; Metallurgy 0 Active
US10617690B2 JAK inhibitor Chemistry; Metallurgy 0 Active
US11834413B2 Antiplatelet drugs and uses thereof Human Necessities 0 Active
US10208047B2 Tertiary alcohol imidazopyrazine BTK inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.